The initiative is called the Fiona and Stanley Druckenmiller Presidential Innovation Fund, named after the donors, according to a Jan. 11 news release from MSK.
The fund will support cancer studies and provide guidance and funding for translational research.
“Over the past years, the Druckenmillers have made a meaningful difference in the lives of our patients at MSK and, by extension, the lives of people with cancer around the world,” MSK President and CEO Craig Thompson, MD, said. “The MSK community is deeply grateful to the Druckenmiller family for their leadership and support of this crucial initiative, which will launch path-breaking research and clinical care efforts and bring hope to so many people with cancer. It is an honor to partner with them in this visionary endeavor.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
